Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection

Lancet Neurology
Stefan TeipelAndreas Fellgiebel

Abstract

Alzheimer's disease is a progressive neurodegenerative disease that typically manifests clinically as an isolated amnestic deficit that progresses to a characteristic dementia syndrome. Advances in neuroimaging research have enabled mapping of diverse molecular, functional, and structural aspects of Alzheimer's disease pathology in ever increasing temporal and regional detail. Accumulating evidence suggests that distinct types of imaging abnormalities related to Alzheimer's disease follow a consistent trajectory during pathogenesis of the disease, and that the first changes can be detected years before the disease manifests clinically. These findings have fuelled clinical interest in the use of specific imaging markers for Alzheimer's disease to predict future development of dementia in patients who are at risk. The potential clinical usefulness of single or multimodal imaging markers is being investigated in selected patient samples from clinical expert centres, but additional research is needed before these promising imaging markers can be successfully translated from research into clinical practice in routine care.

References

Jul 19, 2001·Journal of the National Cancer Institute·M S PepeY Yasui
Nov 22, 2001·JAMA : the Journal of the American Medical Association·D H SilvermanM E Phelps
Nov 14, 2006·Neurobiology of Aging·Tero TapiolaHilkka Soininen
Jun 15, 2007·Archives of Neurology·Basil H RidhaNick C Fox
Mar 15, 2008·Brain : a Journal of Neurology·Milos D IkonomovicSteven T DeKosky
Nov 20, 2008·Journal of Neuropathology and Experimental Neurology·Stefanie H FreemanBradley T Hyman
Apr 1, 2009·Journal of Neurology, Neurosurgery, and Psychiatry·V L VillemagneS J Collins
May 22, 2009·NeuroImage·Aniket JoshiJeffrey A Fessler
Feb 24, 2010·Proceedings of the National Academy of Sciences of the United States of America·Bharat B BiswalMichael P Milham
Mar 17, 2010·NeuroImage·Kelvin K LeungUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Apr 16, 2010·Journal of Neurology, Neurosurgery, and Psychiatry·Elisa ScolaAndrea Falini
Jul 2, 2010·Neurology·S M LandauUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Sep 21, 2010·Behavioural Brain Research·Feng BaiZhijun Zhang
Oct 6, 2010·The Journal of Nutrition, Health & Aging·H KaduszkiewiczUNKNOWN AgeCoDe Study Group
Oct 12, 2010·Brain : a Journal of Neurology·Clifford R JackUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jan 20, 2011·JAMA : the Journal of the American Medical Association·Christopher M ClarkUNKNOWN AV45-A07 Study Group
Feb 1, 2011·NeuroImage·Kewei ChenUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jul 19, 2011·NeuroImage·Eric WestmanUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jul 23, 2011·Lancet Neurology·Michela PievaniGiovanni B Frisoni
Mar 30, 2012·PloS One·Daoqiang ZhangUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Apr 17, 2012·Nuclear Medicine and Biology·Michelle T Fodero-TavolettiRoberto Cappai

❮ Previous
Next ❯

Citations

Jan 26, 2016·Expert Review of Neurotherapeutics·Jan Kassubek, Hans-Peter Müller
Apr 21, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Jorge CabelloSibylle I Ziegler
Apr 22, 2016·Journal of Neural Transmission·Kurt A Jellinger, Gregor K Wenning
Apr 24, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Garibotto ValentinaPagani Marco
Jul 1, 2016·Brain Structure & Function·Majnu JohnJanina Ferbinteanu
Jul 21, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Lisa SchützHenryk Barthel
Oct 18, 2016·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·D P Devanand
Nov 17, 2016·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Federica AgostaMassimo Filippi
Feb 28, 2017·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Arno de WildeWiesje M van der Flier
Apr 21, 2017·Biological Psychiatry : Cognitive Neuroscience and Neuroimaging·Peter J UhlhaasJoachim Gross
Mar 21, 2017·Neurobiology of Aging·Mara Ten KateUNKNOWN Geneva Task Force for the Roadmap of Alzheimer's Biomarkers
Dec 19, 2016·Seminars in Nuclear Medicine·Atul MallikSatoshi Minoshima
Feb 23, 2017·Journal of Alzheimer's Disease : JAD·Francis T HaneZoya Leonenko
Jul 1, 2017·Cognitive Neuropsychology·David BergeronRobert Laforce
Jan 25, 2017·NeuroImage. Clinical·Elaheh MoradiUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Oct 14, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Jochen HammesThilo van Eimeren
Nov 15, 2017·PloS One·Javier RaseroUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Mar 9, 2018·Journal of Magnetic Resonance Imaging : JMRI·Kevin T ChenCiprian Catana
Oct 27, 2017·F1000Research·Leonardo IaccarinoDaniela Perani
Dec 21, 2018·Human Brain Mapping·Liqun KuangUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Feb 15, 2019·Journal of Neural Transmission·Heather WilsonMarios Politis
Nov 30, 2018·Current Alzheimer Research·Bin ZhouZhen Hong
Apr 4, 2017·Biostatistics·Atsushi KawaguchiUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jul 12, 2019·European Journal of Nuclear Medicine and Molecular Imaging·Gérard N BischofUNKNOWN MINC faculty
Sep 22, 2018·Brain : a Journal of Neurology·Miguel Ángel Araque CaballeroMichael Ewers
Jul 22, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Robert LaforceRik Ossenkoppele
Oct 28, 2019·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Jack Albright
Nov 2, 2019·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Jorge JovicichUNKNOWN SRA-NED JPND Working Group
Oct 20, 2017·Neurology·Michel J GrotheUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Aug 18, 2020·Journal of Alzheimer's Disease : JAD·Cyrus A RajiDaniel H S Silverman
Jul 25, 2017·Frontiers in Aging Neuroscience·Javier RaseroUNKNOWN Alzheimer’s Disease Neuroimaging Initiative

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Aging Epidemiology

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Brain Aging

Here is the latest research on intrinsic and extrinsic factors, as well as pathways and mechanisms that underlie aging in the central nervous system.

Cell Aging

This feed focuses on cellular aging with emphasis on mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.